Updates
Added by St. 2024, c. 285, § 22, effective March 23, 2025
Section 122B
(a)
No insurer authorized to issue policies on the lives of persons in the commonwealth shall make a distinction or otherwise discriminate between persons, reject an applicant, cancel a policy or demand or require a higher rate of premium for reasons based solely upon the fact that an applicant or insured has or had a prescription for, purchased or otherwise possessed an opioid antagonist, as defined in section 19B of chapter 94C.
(b)
A violation of this section shall constitute an unfair method of competition or unfair and deceptive act or practice pursuant to chapters 93A and 176D.
Contact
Online
Last updated: | December 23, 2024 |
---|